Prosecution Insights
Last updated: November 20, 2026

Robert M Kelly, USPTO Patent Examiner

Listed by the USPTO as KELLY, ROBERT M

Tech Center 1600 • Art Units: 1615 1631 1633 1638 1651 1654 1656

This examiner grants 74% of resolved cases

Analysis

KELLY, ROBERT M handles prosecution in Tech Center 1600 and Art Unit 1615. The profile covers 953 resolved cases, with a 74.0% allowance rate and a 24.4% interview lift. Those figures indicate a substantial examination record in which interviews are associated with a meaningful increase in allowance outcomes. The allowance rate is materially higher than the interview lift, so the overall disposition record provides the broader signal for evaluating prosecution strategy.

The median time to allowance is 1058 days. Practitioners should therefore account for a lengthy prosecution cycle when planning claim amendments, continuation timing, and client expectations. The listed companies include Figene LLC, The Regents of the University of California, and Krystal Biotech Inc. The listed firms are NORTON ROSE FULBRIGHT US LLP, Casimir Jones, S.C., and MARSHALL, GERSTEIN & BORUN LLP. These organizations identify recurring participants in the available case record and can provide useful context when benchmarking matters before this examiner.

Written from this page's own data; every figure is computed from USPTO records and verified before publication.

Performance Statistics

74.0%
Allow Rate
+14.0% vs TC avg
991
Total Applications
+24.4%
Interview Lift
1058
Avg Prosecution Days
Based on 953 resolved cases, 2023–2026

Rejection Statute Breakdown

4.5%
§101 Eligibility
15.9%
§102 Novelty
18.9%
§103 Obviousness
43.2%
§112 Clarity

Currently Pending Office Actions

App #TitleStatusAssignee
18745400 PLATFORM FOR GENERATING SAFE CELL THERAPEUTICS Non-Final OA The Regents of the University of California
18342642 METHODS OF TREATING LYSOSOMAL DISORDERS Final Rejection The Regents of the University of California
18942735 COMMENSAL FUNGUS AND USES THEREOF Non-Final OA YEDA RESEARCH AND DEVELOPMENT CO. LTD.
18818917 MOTOR UNIT CHIP, MANUFACTURING METHOD THEREOF AND METHOD OF DETECTING PATHOLOGICAL EVENT USING THE SAME Non-Final OA REGENTS OF THE UNIVERSITY OF MINNESOTA
18587729 METHODS FOR ALLOGENIC HEMATOPOIETIC STEM CELL TRANSPLANTATION Final Rejection The Board of Trustees of the Leland Stanford Junior University
18467826 PHARMACEUTICAL COMPOSITION FOR TREATING NON-ALCOHOLIC FATTY LIVER, NON-ALCOHOLIC STEATOHEPATITIS, OR HEPATIC FIBROSIS USING SSU72 PROTEIN OR A POLYNUCLEOTIDE ENCODING THE SAME Final Rejection RESEARCH & BUSINESS FOUNDATION SUNGKYUNKWAN UNIVERSITY
17767856 ONCOLYTIC VIRUSES THAT EXPRESS MULTI-SPECIFIC IMMUNE CELL ENGAGERS Final Rejection Arizona Board of Regents on Behalf of Arizona State University
19147007 COMPOSITIONS COMPRISING SUPRAMOLECULAR ASSEMBLIES OF PEPTIDE AMPHIPHILES AND ORGANIC CATIONS AND METHODS OF USE THEREOF Non-Final OA Northwestern University
18511568 DYSTROPHIN CONSTRUCTS CONTAINING R11-R12 Non-Final OA THE CURATORS OF THE UNIVERSITY OF MISSOURI
18545176 Combination Treatment Non-Final OA Duke University
18527005 COMPOSITIONS AND METHODS FOR DELIVERY OF NUCLEIC ACIDS TO CELLS Non-Final OA Yale University
17829087 RESTIMULATION OF CRYOPRESERVED TUMOR INFILTRATING LYMPHOCYTES Final Rejection Iovance Biotherapeutics Inc.
18699193 METHODS FOR PREVENTING INTER-DROPLET TRANSFER OF A FLUORESCENT PRODUCT IN AQUEOUS DROPLETS BY FORMING A SOLUBLE COMPLEX WITH CYCLODEXTRIN Final Rejection PATTERN BIOSCIENCE, INC.
18703201 METHODS OF USE AND ADMINISTRATION OF ENCAPSULATED CELLS Non-Final OA William Marsh Rice University

Facing This Examiner?

IP Author analyzes examiner patterns and generates tailored response strategies with the highest chance of allowance.

Build Your Strategy

Who Appears Before This Examiner

Top companies before this examiner

Law firms appearing most often

Frequently Asked Questions

What is examiner Robert M Kelly's allowance rate?

74.0% of resolved applications examined by Robert M Kelly were allowed (953 resolved cases), compared with 43.8% across Art Unit 1615 over the last five years.

Does an interview help with examiner Robert M Kelly?

This examiner's interview lift is +24.4 percentage points: the difference in allowance rate between resolved applications that had an examiner interview and those that did not.

How long does examiner Robert M Kelly take to allow a patent?

Applications allowed by Robert M Kelly took 1,058 days on average from filing to allowance.

Which art unit does examiner Robert M Kelly work in?

Robert M Kelly examines applications in Art Unit 1615 in Tech Center 1600 (Biotechnology & Pharmaceuticals).

Sign in with your work email

Enter your email to receive a magic link. No password needed.

Personal email addresses (Gmail, Yahoo, etc.) are not accepted.

Free tier: 3 strategy analyses per month